In NAFLD mice, liraglutide could improve the hypoadiponectinemia-induced inflammatory stress by inhibiting the MKK4/JNK signaling pathway, inhibit liver adipogenesis by activating AMPK, and induce autophagy through the AMPK/mTOR pathway, hence improving the levels of liver lipids (198)
J Pineal Res 54(3):303312
If your vial is 30 mg/mL, 50 units delivers 15 mg, which is the maximum therapeutic dose and would be dangerous for anyone who has not spent months gradually titrating to that level
Veldhuis JD, Keenan DM, Bailey JN, et al
[1] While the term "bloating" specifically is not listed in the FDA prescribing information, related gastrointestinal symptoms such as abdominal distension and dyspepsia are among the commonly reported side effects with tirzepatide therapy
The breakdown provided helps you understand the cost over time